期刊
CANCER CELL
卷 39, 期 2, 页码 257-+出版社
CELL PRESS
DOI: 10.1016/j.ccell.2021.01.001
关键词
-
资金
- King's College London
- Guy's AMP
- St Thomas' Foundation NHS Trust
- KCL Charity funds [PS10822]
- MRC [T005106]
- Cancer Research UK [C56773/A24869]
- Breast Cancer Now
- S.I. at King's College London
- Wellcome Trust [106292/Z/14/Z]
- Rosetrees and John Black Charitable Foundation [11130]
- Cancer Research UK Cancer Immunotherapy Accelerator
- UK COVID-Immunology-Consortium (CIC) [C33499/A20265]
- MRC [MR/T005106/1, MR/L006278/1] Funding Source: UKRI
The study found that solid cancer patients exposed to SARS-CoV-2 exhibit immune signatures similar to COVID-19 patients, while hematological cancer patients show more complex immune responses that may affect treatment and recovery. Recovery from SARS-CoV-2 infection leaves distinct immunological legacies in hematological cancer patients.
Given the immune system's importance for cancer surveillance and treatment, we have investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients display a dominant impact of SARS-CoV-2, apparent from the resemblance of their immune signatures to those for COVID-19(+) non-cancer patients. This is not the case for hematological malignancies, with virus-exposed patients collectively displaying heterogeneous humoral responses, an exhausted T cell phenotype and a high prevalence of prolonged virus shedding. Furthermore, while recovered solid cancer patients' immunophenotypes resemble those of non-virus-exposed cancer patients, recovered hematological cancer patients display distinct, lingering immunological legacies. Thus, while solid cancer patients, including those with advanced disease, seem no more at risk of SARS-CoV-2-associated immune dysregulation than the general population, hematological cancer patients show complex immunological consequences of SARS-CoV-2 exposure that might usefully inform their care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据